# US 2006/0153908 A1 · Spherical pellet formulations

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0153908 A1
- Document ID: US20060153908A1
- Status: Published application
- Kind: A1
- Application number: 10/519,018
- Filed: 2003-06-25
- Published: 2006-07-13
- Earliest claimed: 2002-06-27
- Inventors: Brian Strong; Martin Kloemkes; Dieter Bachmann
- Web page: https://patentgrep.com/patent/US20060153908A1

## CPC

- A61K 31/135: having aromatic rings {, e.g. ketamine, nortriptyline (methadone A61K31/137)}
- A61K 9/1617: {Organic compounds, e.g. phospholipids, fats}
- A61K 9/1652: {Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623)}
- A61P 29/02: without antiinflammatory effect
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

A process for preparing spherical pellets comprising (a) a water-soluble active ingredient soluble, freely soluble or very soluble in water; and in particular having a water-solubility of ≧0.5 g/ml; (b) a spheronizing agent; (c) a dry lubricant, said method comprising preparing a mixture of the active ingredient, the spheronising agent, the dry lubricant; and an amount of water which is less than 5%, w/w relative to the total weight of the mixture; extruding said mixture to obtain an extrudate; and spheronising the extrudate to form spherical pellets. The invention further concerns pellets obtained by this process and sustained release oral dosage forms containing said pellets.

## Claims

### Claim 1

A process for manufacturing spherical pellets comprising
(a) a water-soluble active ingredient which is soluble, freely soluble or very soluble in water;
(b) a spheronizing agent; and
(c) a dry lubricant;
said method comprising preparing a mixture of the active ingredient, the spheronising agent, the dry lubricant; and an amount of water which is less than 5%, w/w relative to the total weight of the mixture; extruding said mixture to obtain an extrudate; and
spheronising the extrudate to form spherical pellets.

### Claim 2 (depends on 1)

A process according to claim 1 wherein the pellets are subsequently coated with a suitable coating.

### Claim 3

A spherical pellet comprising
(a) a water-soluble active ingredient which is soluble, freely soluble or very soluble in water;
(b) a spheronizing agent; and
(c) a dry lubricant.

### Claim 4 (depends on 3)

A spherical pellet according to claim 3 comprising
(a) from 0.1 to about 50% of a water-soluble active ingredient which is soluble, freely soluble or very soluble in water;
(b) from about 25% to about 90% of a spheronizing agent; and
(c) from about 2% to about 50% of a dry lubricant.

### Claim 5 (depends on 3)

A spherical pellet according to claim 3 comprising
(a) from about 1% to about 40% of a water-soluble active ingredient which is soluble, freely soluble or very soluble in water;
(b) from about 20% to about 70% of a spheronizing agent; and
(c) from about 10% to about 35% of a dry lubricant.

### Claim 6 (depends on 3)

A spherical pellet according to claim 3 comprising
(a) from about 1% to about 50% of tramadol or a pharmaceutically acceptable acid-addition salt thereof, in particular tramadol hydrochloride;
(b) from about 15% to about 90% of micro-crystalline cellulose; and
(c) from about 10% to about 35% of a glyceryl fatty ester, in particular a C22-26 fatty acid mono-, di- or triglycerides mixture.

### Claim 7 (depends on 3)

A spherical pellet according to claim 3 wherein the pellet has a low water content.

### Claim 8 (depends on 3)

A spherical pellet according to claim 3, wherein the active ingredient in the pellets is tramadol, or a pharmaceutically acceptable acid addition salt thereof.

### Claim 9 (depends on 3)

A spherical pellet according to claim 3 that is coated.

### Claim 10 (depends on 3)

A pharmaceutical dosage form containing spherical pellets or coated spherical pellets as claimed in claim 3.

### Claim 11 (depends on 3, 10)

A dosage form according to claim 10, which is a capsule filled with pellets or coated pellets as claimed in claim 3.

### Claim 12 (depends on 11)

A process for manufacturing a pharmaceutical dosage form as claimed in claim 11, said method comprising filling the pellets into a suitable container, or in particular into a capsule.

### Claim 13 (depends on 1)

The process according to claim 1 wherein the water-soluble active ingredient has a water-solubility of greater than 0.5 g/ml.

### Claim 14 (depends on 3)

The process according to claim 3 wherein the water-soluble active ingredient has a water-solubility of greater than 0.5 g/ml.

### Claim 15 (depends on 4)

The process according to claim 4 wherein the water-soluble active ingredient has a water-solubility of greater than 0.5 g/ml.

### Claim 16 (depends on 5)

The process according to claim 5 wherein the water-soluble active ingredient has a water-solubility of greater than 0.5 g/ml.

### Claim 17 (depends on 6)

A spherical pellet according to claim 6 wherein the pellet has a low water content.

### Claim 18 (depends on 6)

A spherical pellet according to claim 6 wherein the active ingredient in the pellets is tramadol, or a pharmaceutically acceptable acid addition salt thereof.

### Claim 19 (depends on 6)

A spherical pellet according to claim 6 that is coated.

### Claim 20 (depends on 6)

A pharmaceutical dosage form containing spherical pellets or coated spherical pellets as claimed in claim 6.
